Skip to main content

Table 4 Susceptibility of pathogens in different infections for antibiotics commonly used in mono- or combination therapy

From: Antimicrobial resistance in patients with decompensated liver cirrhosis and bacterial infections in a tertiary center in Northern Germany

Antibiotic agent SBP BSI UTI
S R S R S R
n % n % n % n % n % n %
Ampicillin/sulbactam 51 60.7 33 39.3 31 56.4 24 43.6
Piperacillin/tazobactam 55 65.5 29 34.5 30 53.6 26 46.4 36 65.5 19 34.5
Amoxicillin-/clavulanic acid 12 46.2 14 53.8
Cefpodoxime 18 40.0 27 60.0
Cefuroxime 37 46.3 43 53.8 23 45.1 28 54.9
Ceftriaxone 21 26.3 59 73.8 16 27.6 42 72.4 22 38.6 35 61.4
Fosfomycin 15 88.2 2 11.8
Levofloxacin 32 59.3 22 40.7
Ciprofloxacin 25 73.5 9 26.5
Meropenem 54 73.0 20 27.0 34 64.2 19 35.8 31 83.8 6 16.2
Vancomycin 63 74.1 22 25.9 40 70.2 17 29.8
Cotrimoxazole 27 48.2 29 51.8
Nitrofurantoin 10 100 0 0.0
Ampicillin/sulbactam/vancomycin 76 90.5 8 9.5 49 89.1 6 10.9 27 96.4 1 3.6
Piperacillin/tazobactam/vancomycin 79 94.0 5 6.0 48 85.7 8 14.3 26 100 0 0.0
Meropenem/vancomycin 73 100 0 0.0 52 98.1 1 1.9 8 100 0 0.0
Ceftriaxone/vancomycin 72 91.1 7 8.9 52 92.9 4 7.1 26 96.3 1 3.7
  1. SBP spontaneous bacterial peritonitis, BSI bloodstream infection, UTI urinary tract infection, n number of susceptible or resistant results, S susceptible, R resistant